We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Guidance on improving quality of life for cancer survivors.
Quarterly updates to the emergency presentations of cancer data by Public Health England.
Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.
Innovative researchers working to tackle some of the hardest-to-treat cancers, including through the use of AI, have received a £2 million funding boost.
You may need to tell DVLA if you have lung cancer - download the correct form if you need to let them know
Lead and co-ordinate PHE’s cancer-related work to support the Independent Cancer Taskforce recommendations to prevent and beat cancer.
Collection of cancer survival statistics produced by the UK Health Security Agency (UKHSA).
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Information on the NHS Cervical Screening Programme, including commissioning, quality assurance, education and training.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
These guidelines give commissioners, providers and healthcare professionals in cancer screening information on consent to screening and procedures.
This document explains the Prostate Cancer Risk Management Programme (PCRMP), PSA testing and evidence against a national screening programme.
Acting as an attorney - duties, including registering a lasting power, starting to act, gifting, handling disputes and replacement attorney responsibilities.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).